Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Net Sales
530.49
357.76
415.64
254.68
280.98
233.70
200.97
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
530.49
357.76
415.64
254.68
280.98
233.70
200.97
Raw Material Cost
330.16
231.50
320.88
257.44
242.77
209.56
215.41
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
11.11
12.22
16.38
9.64
9.80
10.42
9.99
Selling and Distribution Expenses
42.50
31.94
45.58
28.74
30.20
13.39
18.50
Other Expenses
0.94
-0.09
-0.26
0.29
0.42
0.18
0.76
Total Expenditure (Excl Depreciation)
393.13
274.80
380.23
298.75
287.02
235.20
251.48
Operating Profit (PBDIT) excl Other Income
137.4
83
35.4
-44.1
-6
-1.5
-50.5
Other Income
-2.66
-2.92
3.14
2.14
3.88
30.75
8.15
Operating Profit (PBDIT)
170.31
121.02
71.94
-3.10
47.88
64.77
-160.17
Interest
11.11
12.22
16.38
9.64
9.80
10.42
9.99
Exceptional Items
0.37
-0.41
-1.27
0.00
0.00
0.00
-0.24
Gross Profit (PBDT)
200.33
126.27
94.76
-2.77
38.21
24.13
-14.44
Depreciation
49.20
49.20
46.09
46.09
46.64
46.64
42.18
Profit Before Tax
110.38
59.20
8.20
-58.83
-8.57
7.71
-212.58
Tax
-1.51
-0.26
-8.28
-1.14
0.07
7.10
-14.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
115.75
61.20
7.73
-55.84
-9.15
2.24
-210.03
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
115.75
61.20
7.73
-55.84
-9.15
2.24
-210.03
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.10
-1.74
-3.01
-1.85
-1.45
-1.63
-1.22
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
112.64
59.46
4.71
-57.69
-10.60
0.61
-211.24
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
2,363.92
2,246.76
2,183.80
2,148.56
2,174.72
2,182.92
2,180.47
Earnings per share (EPS)
0.21
0.11
0.01
-0.1
-0.02
0.0
-0.39
Diluted Earnings per share
0.21
0.11
0.01
-0.1
-0.02
0.0
-0.39
Operating Profit Margin (Excl OI)
23.33%
20.89%
5.46%
-20.15%
-0.94%
-5.4%
-104.74%
Gross Profit Margin
30.08%
30.3%
13.06%
-5.0%
13.55%
23.26%
-84.79%
PAT Margin
21.82%
17.11%
1.86%
-21.93%
-3.26%
0.96%
-104.51%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2026 is 48.27% vs -13.91% in Mar 2026
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2026 is 89.24% vs 1,165.96% in Mar 2026
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2026 is 39.63% vs 80.09% in Mar 2026
Interest
QoQ Growth in quarter ended Jun 2026 is -9.02% vs -25.61% in Mar 2026
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
Compare Quarterly Results Of Jiangxi Fushine Pharmaceutical Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(CNY)
Change(%)
Net Sales
530.49
0
530.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
530.49
0
530.49
Raw Material Cost
330.16
0
330.16
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
11.11
0
11.11
Selling and Distribution Expenses
42.50
0
42.50
Other Expenses
0.94
0.00
0.94
Total Expenditure (Excl Depreciation)
393.13
0
393.13
Operating Profit (PBDIT) excl Other Income
137.36
0.00
137.36
Other Income
-2.66
0
-2.66
Operating Profit (PBDIT)
170.31
0
170.31
Interest
11.11
0
11.11
Exceptional Items
0.37
0
0.37
Gross Profit (PBDT)
200.33
0
200.33
Depreciation
49.20
0
49.20
Profit Before Tax
110.38
0
110.38
Tax
-1.51
0
-1.51
Provisions and contingencies
0
0
0.00
Profit After Tax
115.75
0
115.75
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
115.75
0
115.75
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.10
0
-3.10
Other related items
0.00
0.00
0.00
Consolidated Net Profit
112.64
0
112.64
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
2,363.92
0
2,363.92
Earnings per share (EPS)
0.21
0
0.21
Diluted Earnings per share
0.21
0
0.21
Operating Profit Margin (Excl OI)
23.33%
0%
0.00
23.33%
Gross Profit Margin
30.08%
0%
0.00
30.08%
PAT Margin
21.82%
0%
0.00
21.82%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 53.05 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 48.27% vs -13.91% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 88.79% vs -17.84% in Jun 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 11.26 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 89.24% vs 1,165.96% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 1,162.26% vs 59.70% in Jun 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 17.30 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is 39.63% vs 80.09% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 293.18% vs 4,300.00% in Jun 2025
Quarterly - Interest
Interest 1.11 Million
in Jun 2026Figures in Million
QoQ Growth in quarter ended Jun 2026 is -9.02% vs -25.61% in Mar 2026
YoY Growth in quarter ended Jun 2026 is 13.27% vs -1.01% in Jun 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 23.33%
in Jun 2026Figures in %
QoQ Growth in quarter ended Jun 2026 has improved from Mar 2026
YoY Growth in quarter ended Jun 2026 has improved from Jun 2025
Footer loading
